IRADIMED CORPORATION Dividends Paid
IRADIMED CORPORATION (IRMD) reported Dividends Paid of $5.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividends · last filed 2026-07-31
- IRADIMED CORPORATION payments of dividends for the quarter ending 2026-06-30 was $2.56M, a 18.32% increase year-over-year.
- IRADIMED CORPORATION payments of dividends for the quarter ending 2026-03-31 was $2.56M, a 18.22% increase year-over-year.
- IRADIMED CORPORATION payments of dividends for the quarter ending 2025-12-31 was $8.55M, a 350.02% increase year-over-year.
- IRADIMED CORPORATION payments of dividends for the quarter ending 2025-09-30 was $2.16M, a 13.80% increase year-over-year.
- IRADIMED CORPORATION payments of dividends for fiscal 2025 was $15.04M, a 9.97% increase from fiscal 2024.
- IRADIMED CORPORATION payments of dividends for fiscal 2024 was $13.68M, a 3.43% increase from fiscal 2023.
- IRADIMED CORPORATION payments of dividends for fiscal 2023 was $13.22M, a 5.29% increase from fiscal 2022.
- IRADIMED CORPORATION payments of dividends for fiscal 2022 was $12.56M.
| Period end | Payments of Dividends 3 month | Payments of Dividends 3 month as first filed | Payments of Dividends 6 month | Payments of Dividends 6 month as first filed | Payments of Dividends 9 month | Payments of Dividends 12 month | Payments of Dividends 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $5.11M 10-Q · filed 2026-07-31 | $13.67M derived: sum of 3 quarters · filed 2026-07-31 | $15.83M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2026-03-31 | $2.56M 10-Q · filed 2026-05-01 | $11.11M derived: sum of 2 quarters · filed 2026-05-01 | $13.27M derived: sum of 3 quarters · filed 2026-05-01 | $15.43M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-12-31 | $8.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $10.72M derived: sum of 2 quarters · filed 2026-03-06 | $12.88M derived: sum of 3 quarters · filed 2026-07-31 | $15.04M 10-K · filed 2026-03-06 | |||
| 2025-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $4.32M derived: sum of 2 quarters · filed 2026-07-31 | $6.49M 10-Q · filed 2025-11-03 | $8.39M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-06-30 | $2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $4.32M 10-Q · filed 2026-07-31 | $4.32M 10-Q · filed 2025-08-01 | $6.22M derived: sum of 3 quarters · filed 2026-07-31 | $8.12M derived: sum of 4 quarters · filed 2026-07-31 | ||
| 2025-03-31 | $2.16M 10-Q · filed 2026-05-01 | $2.16M 10-Q · filed 2025-05-05 | $4.06M derived: sum of 2 quarters · filed 2026-05-01 | $5.96M derived: sum of 3 quarters · filed 2026-05-01 | $7.86M derived: sum of 4 quarters · filed 2026-05-01 | ||
| 2024-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $3.80M derived: sum of 2 quarters · filed 2026-03-06 | $5.70M derived: sum of 3 quarters · filed 2026-03-06 | $13.68M 10-K · filed 2026-03-06 | $13.68M 10-K · filed 2025-03-06 | ||
| 2024-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $3.80M derived: sum of 2 quarters · filed 2025-11-03 | $11.78M 10-Q · filed 2025-11-03 | $11.78M derived: sum of 4 quarters · filed 2025-11-03 | |||
| 2024-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $9.88M 10-Q · filed 2025-08-01 | $9.88M derived: sum of 3 quarters · filed 2025-09-03 | $9.88M derived: sum of 4 quarters · filed 2025-09-03 | |||
| 2024-03-31 | $7.98M 10-Q · filed 2025-05-05 | $7.98M derived: sum of 2 quarters · filed 2025-09-03 | $7.98M derived: sum of 3 quarters · filed 2025-09-03 | $7.98M derived: sum of 4 quarters · filed 2025-09-03 | |||
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03 | $0.00 derived: sum of 2 quarters · filed 2025-09-03 | $0.00 derived: sum of 3 quarters · filed 2025-09-03 | $13.22M 10-K/A · filed 2025-09-03 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $13.22M 10-Q · filed 2024-10-31 | $13.22M derived: sum of 4 quarters · filed 2024-10-31 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $13.22M 10-Q · filed 2024-08-01 | $13.22M derived: sum of 3 quarters · filed 2024-08-01 | $13.22M derived: sum of 4 quarters · filed 2024-08-01 | |||
| 2023-03-31 | $13.22M 10-Q · filed 2024-05-02 | $13.22M derived: sum of 2 quarters · filed 2024-05-02 | $13.22M derived: sum of 3 quarters · filed 2024-05-02 | $13.22M derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $0.00 derived: sum of 2 quarters · filed 2024-03-01 | $0.00 derived: sum of 3 quarters · filed 2024-03-01 | $12.56M 10-K · filed 2024-03-01 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $12.56M 10-Q · filed 2023-11-03 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $12.56M 10-Q · filed 2023-08-03 | |||||
| 2022-03-31 | $12.56M 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |